[{"Assets_0_Q1_USD":35798000000.0,"CommonStockSharesConverted_0_Q1_shares":349219074.0,"CommonStockSharesOutstanding_0_Q1_shares":349219074.0,"EarningsPerShareBasic_1_Q1_USD":-7.68,"EarningsPerShareDiluted_1_Q1_USD":-7.68,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":438000000.0,"NetIncomeLossConverted_1_Q1_USD":-2691000000.0,"RevenuesConverted_1_Q1_USD":1965000000.0,"StockholdersEquity_0_Q1_USD":4424000000.0,"StockholdersEquityConverted_0_Q1_USD":4523000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":350700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":350700000.0,"Ticker":"BHC","CIK":"885590","name":"VALEANT PHARMACEUTICALS INTERNATIONAL, INC.","OfficialName":"Bausch Health Companies Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7962573421.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NYSE","SP500":"nan","filed":"20180508"}]